Start date: as soon as possible Duration: at least 2 years Deadline to apply: 1 March 2026
The Verstreken Lab is based in Leuven Belgium and is part of the VIB-KU Leuven Center for Neuroscience. The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative disease. They are also conducting advanced CRISPR screens to interrogate the complex genetic basis of these disorders. The lab has been supported by the ERC for the past 15 years. Now we are seeking a motivated and enthusiastic colleague with strong iPSC experience and disease modelling skills to join our team.
The ultimate goal of this project is to develop and apply advanced human iPSC-based models to study complex genetic architecture of neurodegenerative disorders. The candidate will approach this by: 1) using advanced Brain-on-Chip models to understand how genetic risk affects the function of disease-relevant circuits and eventually use this knowledge to stratify Parkinsons disease; and 2) running CRISPR screens on hiPSC-derived neurons and glia to disentangle the complex genetic interactions that underlie disease causation.
You will work with a team of scientists interested in (1) mechanisms of neurodegeneration (2) cellular determinants of disease (3) functional genomics (3) the development of translational strategies in circuit neuroscience and (4) the development of computational models and methods for neuroscience. The goal is to implement advanced brain-on-chip models and CRISPR-based screens and methodologies to generate mechanistic insights with the ultimate goal of combating Parkinsons disease and other neurodegenerative diseases. You will have access to excellent support facilities including facilities at VIB KU Leuven the Flemish supercomputer and many more.
We are seeking a highly motivated enthusiastic critical and creative individual to join our team. The candidate should have a strong background in iPSC modelling and the use of CRISPR tools and an interest in neurodegenerative diseases.
Essential:
Please complete the online application tool ( and include a motivation letter a detailed CV including a list of publications and the contact information of three referees. We are happy to receive applications until March 1st 2026.
For more information contact or .
Find out more: Website Video Virtual Tour